LCTX Past Earnings

— Presenting past earnings and revenue for Lineage Cell Therapeutics (LCTX) from Q4 2012 to Q4 2025, based on our latest update on 5/7/2026. The past earnings numbers are per-share values while the revenue is the grand total for the quarter. Studying these LCTX past earnings numbers both in chart format and in tables can help investors visualize any typical seasonality patterns, as well as determine whether the company has grown over time.

LCTX Past Earnings Q&A

On this page we presented the LCTX past earnings date information for Lineage Cell Therapeutics. Reviewing that LCTX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2018, when LCTX posted gaap of 0.53/share. Meanwhile the lowest LCTX past earnings result was in Q4 2017, when LCTX posted gaap of -0.58/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2025 when LCTX reported 0.01B in revenue, while the smallest revenue quarter was Q4 2020 when LCTX reported 0.00B in revenue.

Any self directed investor doing their due diligence on LCTX or any other given stock can benefit from researching all of the Lineage Cell Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Lineage Cell Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LCTX. Thanks for visiting, and the next time you need to research LCTX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.